Iterum Therapeutics plc (NASDAQ:ITRM) saw a large growth in short interest in the month of November. As of November 15th, there was short interest totalling 5,430,000 shares, a growth of 26.9% from the October 31st total of 4,280,000 shares. Currently, 3.1% of the company’s shares are sold short. Based on an average trading volume of […]